An HIV testing initiative that targeted male-dominated workplaces and social spaces, and notified the sexual partners of anyone testing positive, results in 25% of men being diagnosed with HIV
New Kenyan trial providing HIV self-tests to sex workers sees high levels of partner testing – and increased condom use when men refused to test
Dutch study finds no evidence to suggest PrEP use increases mental health issues – and may actually help reduce sexual compulsivity and drug-misuse.
Research suggests women with disabilities are significantly more vulnerable to HIV than other women and disabled men – and that this is linked to sexual violence.
Ring containing the antiretroviral drug dapivirine could be available in Africa as early as 2021 after it was found to reduce women’s HIV risk by 30 to 50%.
Journalist Levy Ngosa explores how stigma & discrimination of the LGBT+ community in Zambia stops access to HIV prevention and treatment services
An SMS service co-created with sex workers to improve their sexual health met with keen approval during testing.
Around 70% of people aged 50-plus receiving HIV care in Latin America in 2015 had an NCD, compared to 32% in the year 2000.
The proportion of South Africans ever testing for HIV increased from 30% to 75% between 2005 and 2017 – but differences remain in who is getting tested
When starting treatment in the third trimester, women taking dolutegravir more likely to achieve undetectable viral loads at the time of giving birth compared with those taking efavirenz.
A pilot scheme that immediately rebooks and provides a reminder for an HIV retest six months later increases attendance by 25%.
People on integrase inhibitors found to gain more weight on average than those on other treatment regimens
Modelling finds PrEP has the potential to avert between 3% and 8% of HIV infections in 13 African and Caribbean countries by 2030 if three key populations can access it.
Despite the country’s successful treatment programme, modelling suggests the rate of new infections is likely to rise – unless prevention is strengthened and groups such as migrants included.
Malawi trial finds half of those offered the opportunity to self-test for HIV during an outpatient visit accepted it, compared to less than 15% of those offered provider-initiated testing.
Viral load testing trial finds 49% are virally unsuppressed while one in five are failing their treatment with suspected drug resistance.
